Upgrade to SI Premium - Free Trial

Roivant Sciences (ROIV) PT Raised to $46 at Guggenheim

September 9, 2026 5:39 AM
Guggenheim analyst Yastin Suneja raised the price target on Roivant Sciences (NASDAQ: ROIV) to $46.00 (from $42.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change